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Abstract: 
The protein LGN, named for the many repeats of the amino acids leucine (L), glycine (G) and asparagine 
(N), is crucial for mammalian cellular division. Specifically, LGN plays a significant role in cell polarity and 
alignment of the mitotic spindles and in its absence, the organism ceases to develop. In breast cancer, 
LGN is upregulated due to phosphorylation of T450 and the knockdown of LGN activity has been shown 
to suppress growth of breast cancer cells. Furthermore, a mutation to alanine at the 450th position also 
suppressed breast cancer cell growth. The goal of this project was to explore the biochemistry of both 
wild-type LGN and two T450 mutants of LGN in hope of gaining insight as to how LGN phosphorylation 
proliferates cancer. LGN was transiently expressed in BHK-570 tissue culture cells using a pCMV-LGN 
plasmid and LipoD 293 reagent. Protein expression of wild-type LGN was confirmed by both Western 
blot and immunocytochemistry of fixed, permeabilized cells using anti-GPSM2 antibody. Furthermore, 
the T450A and T450D mutants, which mimic the unphosphorylated and phosphorylated forms of LGN 
respectively, are being generated by PCR and will be sent for sequencing analysis to confirm the 
completed mutagenesis. Future experiments will determine the effect of phosphorylation of T450 on 
LGN function; specifically, additional localization studies of T450A and T450D mutants will be conducted 
and compared to that of wild-type LGN. Characterization of LGN function relative to the phosphorylation 
status of T450 could lead to the development of novel treatments for breast cancer.  
Introduction: 
LGN was first identified in 1996 (1) and was designated as LGN due to the presence of 10 Leu-Gly-Asn 
repeats in the N-terminal half of the protein and was initially classified as a mosaic protein with two 
distinct domains. The N-terminal domain consists of seven tetratricopeptide repeats (TPR) motifs which 
can bind to a wide range of protein targets, including NuMA (2,3,4,5). The C-terminal domain contains 4 
GoLoco motifs, also known as GPR domains, which can bind various Gαi subunits in G-protein regulatory 
mechanisms (1,6). LGN is known to have an estimated molecular mass of 76 kDa (1), have a basal pI of 
6.49 (7), and be expressed in a variety of tissue types including: throughout brain tissue, heart, lung, 
liver, pancreas, spleen, kidney, testis, ovary, and skeletal muscle (1,8). LGN’s official name as approved 
by HUGO Gene Nomenclature Committee is G-Protein Signaling Modulator 2 (GPSM2). Some of LGN’s 
homologs in various organisms including: Pins in drosophila, AGS5 in S. cerevisiae, and GPR1/2 in C. 
elegans. Furthermore, LGN’s direct binding partners have their own homologs such as NuMA’s homolog 
Mud in drosophila (4) and Lin-5 in C. elegans (9). 
LGN was first identified based on its binding interactions with Gαi subunits at the protein’s GoLoco 
motifs, specifically the Gαi2 subunit (1). LGN can bind up to four Gαi subunits, one at each GoLoco motifs. 
Further studies on the selectivity of LGN’s GoLoco motifs revealed that all four domains have a high 
affinity for Gαi1, Gαi2, and Gαi3 but not for Gαo subunits (6). Furthermore, these GoLoco motifs act as 
guanine nucleotide dissociation inhibitors on the Gαi subunits, maintaining the Gαi-GDP complex. The 
interaction of LGN with Gαi-GDP to stabilize the Gαi-GDP complex prevents the reassociation of Gαi to Gβγ 
and allows for Gβγ subunits to continue to stimulate downstream signaling (10). To localize LGN at the 
cell cortex, Gα subunits must be able to interact with the cortical membrane. Myristoylation of Gα 
subunits can tether them to the cell membrane to enrich the presence of LGN to their location (11). 
Furthermore, actin filaments function to anchor and stabilize the presence of Gαi subunits at the cell 
cortex (12). Gα subunits at the cell cortex are essential for the generation of the proper pulling forces by 
the LGN/NuMA/Dynein complex and the extent of these pulling forces is dependent upon Gα activity 
(Figure 1) (11,12). The Ezrin/Radixin/Moesin complex functions to organize F-actin structures at the cell 
cortex during metaphase in order to regulate the localization of Gα and to allow the recruitment of LGN 
and NuMA to the cortex (13). During prophase and metaphase, Gαi subunits are localized at both the cell 
cortex and the spindle poles to direct spindle pole polarity and positioning for cell division (14).  
During interphase, NuMA is localized at the nucleus as part of the nuclear transport machinery and 
nuclear scaffold, however, upon initiation of mitosis and the breakdown of the nuclear envelope, LGN 
will recruit NuMA to the cell cortex (15,16). When bound to LGN, amino acids 1878-1910 of NuMA will 
occupy all of the seven TRP motifs of LGN (17). When not bound to LGN, NuMA will bind to and stabilize 
the minus ends of astral microtubules through amino acids 1900-1971 to promote their formation for 
proper orientation of the mitotic spindles. Due to the 10 amino acid overlapping binding sites on NuMA, 
the latter interaction can be disrupted by LGN binding to NuMA and subsequently suppress astral 
microtubule formation (2,18,19). Further research revealed an alternate microtubule binding domain at 
amino acids 2002-2115 which allow for simultaneous interactions with both LGN and astral 
microtubules to maintain microtubule orientation towards the cell poles (20). During mitosis, NuMA 
colocalizes with LGN at the spindle poles as well as the cell cortex as part of the Gαi/LGN/NuMA complex 
(18). However, it was determined in HeLa cells that NuMA’s localization at the apical cortex during 
metaphase depended on both LGN presence in the apical cortex and the phosphorylation of Y1774 of 
Figure 1: Schematic diagram of protein assembly for force generation and pulling on astral 
microtubules and ultimately one of the sister chromatids during metaphase of mitosis.  
NuMA, which is regulated by the kinase ABL1 (21). In order to generate pulling forces on astral 
microtubules, NuMA in the Gαi/LGN/NuMA complex recruits dynein/dynactin to provide plus-end pulling 
forces on the astral microtubules which works to orient the mitotic spindles and direct cell polarity 
(Figure 1) (22,23). These pulling forces on the astral microtubules function to anchor the microtubules at 
the cell cortex (24) and properly position the microtubules and spindle poles for cell division (25). 
Spindle pole orientation dictates partitioning of cells during mitosis and fate of daughter cells after 
mitosis is completed (26).  
LGN is found to be expressed throughout the cell cycle but its highest expression is during the G2 phase 
and mitosis (27) where it tends to localize at the spindle poles and cell cortex during metaphase and at 
the midline during cytokinesis (14). Specifically, LGN functions to direct cell polarity and orient the 
mitotic spindles during cell division. This is achieved through a series of regulatory steps which work to 
recruit LGN to the cell cortex, activate LGN, allowing LGN to influence further proteins for the regulation 
of mitotic spindles. In mammalian cells, par3/par6/aPKC complexes recruit LGN to the cell cortex 
through the binding of the adapter protein mInsc to LGN (4,15). Similarly, in drosophila, the Baz/Par-
6/aPKC/Insc complex recruits Pins to the apical cortex at late interphase, allowing Pins to subsequently 
bind to Gαi, which is consistent with the Par-3/mInsc interactions with LGN in mammalian systems (17). 
In Chinese Hamster Ovary cells, LGN colocalizes with Gαi3 at the cell cortex during metaphase as well as 
at the spindle poles in order to direct cell polarity (14). At the apical cortex, aPKC phosphorylates LGN at 
S401 which allows for binding of LGN to a 14-3-3 protein, dissociating LGN from Gαi (15). This regulation 
results in an inhibition of LGN orientation activity. LGN activity is also regulated by the protein Ric-8a 
which can enzymatically dissociate the Gαi-GDP/GoLoco interactions by activating Gαi through the 
exchange of a GTP molecule for the bound GDP and subsequently causing the release of NuMA from 
LGN to regulate the pulling force of microtubules during mitosis (28). Another form of regulation for LGN 
is an autoinhibition self-regulation. In cells, LGN is a conformational switch which will form an 
autoinhibited structure where the N- and C-terminal domains of LGN will interact with each other 
(18,29). Specifically, GoLoco motifs 1 and 2 along with GoLoco motifs 3 and 4 will from interactions with 
TRP motifs 0-3 and 4-7, respectively (30). The mechanism leading to the release of this structure and 
binding to Gαi and NuMA is disputed. Some theories state that LGN will first bind to Gαi in the cortical 
poles, releasing the autoinhibited form of LGN allowing for TPR motifs to then bind NuMA (30,31). 
However, at least one report suggests that NuMA will initially bind to LGN, releasing the closed 
conformation of LGN thus allowing for subsequent binding of LGN to Gαi at the cortical positions (18). 
Regardless of order, the binding of either Gαi or NuMA to LGN releases the GoLoco-TPR interactions and 
allows for cooperative binding of both proteins to LGN. In the end, LGN function must be tightly 
controlled to ensure that proper planar divisions occur during development and cells divide evenly (32). 
LGN protein has been found to be upregulated in various forms of breast cancer and is believed to be a 
critical factor in the overactive mitosis of the cancer cells (27). LGN knockdown by siRNAs halted cell 
division and prevented the completion of mitosis. It was demonstrated that phosphorylation of T450 
caused the upregulation through the mutagenesis of T450 to A450 (T450A). This T450A mutant LGN 
induced growth suppression and abnormal chromosomal segregation in breast cancer cells. These 
effects show a potential target to suppress the proliferation of breast cancer. Our research sets out to 
characterize the functions on LGN during the cell cycle in regards to the phosphorylation status of T450. 
This will be done by comparing localization patterns of wild-type LGN to T450A and T450D LGN. These 
mutants have been selected due to their simulation of a potential phosphorylation at the 450th amino 
acid site. The T450A mutant will mimic the lack of phosphorylation whereas the T450D will simulate the 
presence of phosphorylation at T450. To supplement our research on LGN function, LGN protein 
isolation, purification, and crystallography is also being performed in order to determine the 3D crystal 
structure of LGN and the T450 mutants. Understanding the functions and structures of wild-type LGN 
and the T450 mutants will allow us to understand the effects that T450 phosphorylation have on the 
regulation of LGN activity. Further understanding of this regulatory activity could lead to the 
development of breast cancer treatments which block the activation of LGN and prevent proliferation of 
cancer cells.  
Materials and Methods:  
Cells, plasmids, and antibodies 
XL1-Blue supercompetent cells and BL21(DE3) competent cells were purchased from Agilent 
Technologies. Top10 competent cells were purchased from Invitrogen Life Technologies. DH5α cells 
were purchased from Fisher Scientific. BHK-570 cells were kindly donated by Dr. Cook from The College 
at Brockport. 
pET-28a—LGN was kindly donated by Nikolai O. Artemyev at the University of Iowa. pET-15b—LGN was 
purchased from GenScript. pCMV—LGN was purchased from OriGene. 
Rabbit anti-His6 antibody was purchased from GenScript. Rabbit anti-GPSM2 antibody and goat anti-
rabbit HRP-conjugated antibody were purchased from Fisher Scientific. 
LGN Expression and Purification in E. coli 
E. coli cells were grown in 1 L of 2xYT media at 37 °C and 250 rpm in the presence of the proper 
antibiotic for either the pET-28a or pET-15b plasmid (50 μg/mL of kanamycin or 0.14 nM ampicillin, 
respectively). When the cells reached an OD600 of 0.5-0.75, the cells were induced to express LGN by 
isopropyl β-D-1-thiogalactopyranoside (IPTG) (50 or 250 μM). After 16 hours, the cells were centrifuged 
at 7,000 rpm and 4 °C for 10 minutes. The pellet was stored at -20 °C until later. 
LGN was isolated by resuspending cells in 50 mL of the proper chromatography binding buffer (affinity: 
150 mM NaCl, 20 mM phosphate buffer (pH 7.3), 20 mM imidazole; anion-exchange: 20 mM phosphate 
buffer (pH 6.8, 7.3, 7.7, or 8.0) containing 50 mM NaCl and 2 mM β-mercaptoethanol) with one Roche 
cOmplete ULTRA Tablet (EDTA-free) and then sonicated with a Model 505 Sonic Dismembrator from 
Fisher Scientific in an ice water bath with varied conditions of 60% amplitude for 5 minutes, 30% 
amplitude for 5 minutes, 60% amplitude for 2.5 minutes, 40% or 50% amplitude for 2.5 or 3 minutes. 
The cell solution was centrifuged at 13,000 rpm for 35 min at 4 °C and the pellet was discarded. 
The supernatant was loaded onto a HPLC column (Co2+ affinity or Mono Q anion-exchange) with a flow 
rate of 0.5 mL/min. LGN was eluted with 15 mL of the proper elution buffer (affinity: 150 mM NaCl, 20 
mM phosphate buffer (pH 7.3), 250 mM imidazole; anion-exchange: 20 mM phosphate buffer (pH 6.8, 
7.3, 7.7, or 8.0) containing 250 mM NaCl and 2 mM β-mercaptoethanol). Initially, the samples were 
concentrated to under 5 mL using Amicon 15-Ultra 10 kDa MWCO tubes. 
Fractions were analyzed by SDS-PAGE, followed by coomassie blue staining to determine purity or 
transferred to a PVDF membrane for Western blot analysis. A Western blot was performed to detect the 
presence of LGN using either a rabbit anti-His6 or rabbit anti-GPSM2 primary antibody (1:1,000 dilution) 
and a goat anti-rabbit HRP-conjugated secondary antibody (1:5,000 dilution). A colorimetric Pierce 
CN/DAB Substrate kit was used to detect the presence of bands. 
Transformation and Plasmid Purification 
Heat-shock transformation of Top10 Competent cells was performed according to the protocol from 
Invitrogen Life Technologies. 
Electroporation transformation of DH5α cells was performed according to the protocol from Fisher 
Scientific. 
After transfection, cells were allowed to grow for 1 hour in SOC media then subsequently plated on LB 
agar plates containing 50 μg/mL of kanamycin or 0.14 nM ampicillin for growth. Colonies were picked 
and grown in 10 mL of 2xYT media overnight at 37 °C and 250 rpm for protein expression and 
purification or plasmid isolation. 
Maxipreps were preformed according to standard protocols. 
Generation of Mammalian LGN Vector Stock 
The pCMV—LGN plasmid was purchased and transformed into DH5α cells. It was subsequently isolated 
by maxi-prep and stored at -20 °C at a concentration of 1 𝑚𝑚𝑚𝑚
𝑚𝑚𝑚𝑚
. This stock of pCMV—LGN plasmid was 
used for transfection of mammalian cell lines and nested PCR to generate T450 mutant LGN. 
LGN Expression in BHK 
Cell Growth and Maintenance 
BHK-570 cells were grown in DMEM growth media containing 10% FBS at 37 °C and 5% CO2.  
LipoD Transfection 
BHK-570 cells were grown to 80% confluency before the transfection protocol was performed.  First, the 
growth media was changed and the pCMV-LGN plasmid and LipoD reagent were mixed with equal 
volumes of DMEM then were mixed together. After 15-30 minutes of incubation at room temperature, 
the LipoD—pCMV-LGN solution was added dropwise to the cell culture. Cells were allowed to express 
LGN protein for 24 hours. 
Immunofluorescence 
Cells that were adhered to coverslips in 3.5 cm dishes were transfected according to the previously 
mentioned LipoD transfection protocol. After 18-24 hours of expression, cells were fixed on the 
coverslips with 4% paraformaldehyde. Coverslips were incubated in blocking buffer (137 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 0.1% Tween-20, 5% goat serum, pH 7.4) for 30 minutes at 
room temperature. Next, coverslips were incubated overnight at 4 °C with blocking buffer containing 
1:1,000 rabbit anti-GPSM2 antibody. Coverslips were washed for 5 minutes with ice cold PBS 3 times 
and were incubated for 20 minutes at room temperature in blocking buffer containing 1:500 goat anti-
rabbit DyLight 488 conjugated antibody and 1:500 DAPI. Protein localization was determined by 
fluorescent microscopy using a Zeiss AxioSkop with Axiovision Software. 
Mutagenesis protocols 
QuikChange Site-Directed Mutagenesis 
T450A mutagenesis was performed according to Stratagene’s QuikChange Site-Directed Mutagenesis Kit 
manufacturer’s instructions in which 2 µL or 4 µL of full-length LGN DNA template (pET-28a—LGN) was 
used. All mutagenesis products were run on a 1% agarose gel to check for the presence of a plasmid. 
The resulting plasmid was transformed into BL21(DE3) competent cells, XL1-Blue supercompetent cells, 
or Top10 competent cells using the manufacturer’s instructions. The transformed cells were plated on 
LB agar plates containing 50 μg/mL kanamycin. Plates were incubated overnight at 37 °C. Colonies were 
picked and grown in 10 mL of 2xYT media overnight at 37 °C and 250 rpm. The plasmid was isolated 
from the cells grown in the 10 mL of 2xYT media by using the GeneJET Plasmid Miniprep kit purchased 
from Fisher Scientific. The miniprep product was run on a 1% agarose gel to confirm the presence of a 
plasmid. 
Site-Directed Mutagenesis 
PCR site-directed mutagenesis was performed based on instructions from Agilent Technologies. 
Template DNA (pET-15b—LGN) remaining after the PCR reaction was digested with 1 μL of DpnI for 1 
hour at 37 °C. Products were run on a 1% agarose gel and extracted using a gel extraction kit from 
Qiagen or Fisher Scientific. 
Nested PCR Mutagenesis 
Nested PCR was performed to generate the T450A and T450D mutants using pCMV—LGN. First, two 
rounds of PCR were performed: the first reaction used a primer at a site upstream of LGN on the 
template strand and a primer coding for the respective mutation at the T450 site on the non-template 
strand; the second used a primer at a site downstream of LGN on the non-template strand and a primer 
coding for the respective mutation at the T450 site on the template strand. Products were run on a 1% 
agarose gel and extracted using a gel extraction kit purchased from Fisher Scientific. A final PCR is 
performed using the previously generated segments along with the primer at a site upstream of LGN on 
the template strand and the primer at a site downstream of LGN on the non-template strand to 
generate the full length mutant LGN segment. The product was then run on a 1% agarose gel and 
extracted using a gel extraction kit and ligated into an empty pCMV plasmid using NotI. 
Immunoprecipitation 
The entire process was performed on ice at 4 °C. Cells were chilled and washed with ice cold PBS. Cells 
were lysed with lysis buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 1% NP-40, 1 mM EDTA, 1:1,000 
protease & nuclease inhibitor cocktail from Sigma Aldrich) and incubated for 5 minutes. Lysates were 
scraped off of the dish and the solution was transferred to chilled microfuge tubes and incubated for 20 
minutes. Microfuge tubes were centrifuged at 13,200 rpm for 10 minutes at 4 °C and the supernatant 
was decanted to clean, chilled microfuge tubes. One μL of rabbit anti-GPSM2 antibody was added to the 
solution and incubated overnight at 4 °C with gentle rocking. Eighty μL of protein A/G Plus-Agarose 
beads were added to the solution and incubated for 1 hour at 4 °C with gentle rocking. The solution was 
centrifuged at 13,200 rpm for 2 minutes and 4 °C to pellet the beads and the supernatant was decanted. 
The pellet was resuspended in IP wash buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 0.1% NP-40, 1 mM 
EDTA) and centrifuged at 13,200 rpm for 2 minutes and 4 °C to pellet the beads; the wash and 
centrifugation steps were repeated 4 times. During the last wash, the pellet was resuspended and 
equally distributed into four clean, chilled microfuge tubes.  To isolate and purify LGN by itself, GPSM2 
peptide (none, 1:100, 1:500 or 1:1,000) that corresponds to the GPSM2 antibody was added to the 
beads at 4 °C for 16 hours with gentle rocking. The solution was centrifuged at 13,200 rpm for 2 minutes 
and 4 °C and the supernatant was transferred to a clean microfuge tube. The presence of LGN protein 
was analyzed by SDS-PAGE and Western blot using the anti-GPSM2 antibody followed by film detection.  
Figure 2: Schematic representation of pET-28a—LGN (A) 
and pET-15b—LGN (B). pET-15b is 5708 bp long and the 
LGN insert is 2031 bp long. 
B A 
Results and Discussion: 
Transformation of LGN Vector into E. coli 
In order to express full length LGN for purification and crystallography, full length LGN vectors were first 
transformed into E. coli cells for protein expression. E. coli were chosen as the expression system 
because they are able to quickly express large amounts of protein. XL1-Blue supercompetent cells, Top 
10 competent cells, and DH5α cells were used for efficient transformation and plasmid propagation. 
BL21(DE3) competent cells were used for efficient protein expression through their expression of the T7 
RNA polymerase for transcription of the vectors (Figure 2).  
After the transformation with pET-
28a—LGN (Figure 2A) directly into 
XL1-Blue Supercompetent cells, the 
cells were grown on LB plates in the 
presence of kanamycin. The ability of 
the XL1-Blue supercompetent E. coli 
cells to grow in the presence of 
kanamycin suggested that a 
transformation of the pET-28a—LGN 
plasmid took place. A subsequent 
isolation of the plasmid from the XL1-
Blue Supercompetent cells was 
performed and then run on a 1% agarose gel to confirm that the transformation was a success but no 
bands were present in the gel. Further attempts to transform the pET-28a—LGN plasmid into XL1-Blue 
supercompetent cells were unsuccessful, resulting in only the growth of satellite colonies. Top10 
competent cells were purchased for initial plasmid transformation protocols in order to clone and purify 
a large amount of plasmid for a subsequent transformation into BL21(DE3) competent cells for protein 
expression via the vector.  
Next, the pET-28a—LGN plasmid from the stock was run on a 1% agarose gel and the band at 7500 kb 
was purified from the gel (Figure 3A). We confirmed that the plasmid was successfully transformed into 
Top10 cells as indicated by the E. coli cells growth on LB agar plates in the presence of the antibiotic 
kanamycin. Subsequent plasmid isolation from the cultured colonies and analysis of the products by 
electrophoresis on a 1% agarose gel resulted in an absence of plasmid at 7500 kb (Figure 3B). Although 
the initial results sugested that a transfromation took place, without confrimation through a subsequnt 
plasmid isolation it cannot be confimed that the Top10 cells actually contain the pET-28a—LGN plasmid. 
Without any positive results using the pET-28a—LGN plasmid, we purchased a pET-15b—LGN plasmid to 
achieve LGN expression in E. coli. 
The pET15b—LGN plasmid was transformed into DH5α cells and the cells were grown on LB agar plates 
containing ampicillin. The vector was subsequently grown in culture, isolated, and verified by restriction 
digest using BamHI, NdeI, BamHI + NdeI, and XhoI and analysis on a 1% agarose gel (Figures 2B and 3C). 
Single digests with NdeI and BamHI resulted in the expected band at 7800 bp, the double digest with 
NdeI and BamHI resulted with two bands at 5700 bp and 2000 bp, and the single digest with XhoI 
resulted in a supercoiled plasmid structure. These results indicate that the pET-15b—LGN plasmid is 
present in the DH5α cells and that the LGN is inserted in the correct orientation within the plasmid. A 
stock of DH5α 
with pET-15b—
LGN in 25% 
glycerol was 
stored at -80 °C 
for future use. 
pET-15b—LGN 
was also 
transformed 
into BL21(DE3) 
E. coli cells, and 
expressed LGN 
when grown in 
both 2xYT and 
LB media. 
Western blot 
analysis after 
one round of 
anion-exchange 
purification of 
LGN expression 
Figure 3: Analysis of the presence of various LGN vectors in E. coli cells. A) pET-
28a—LGN vector from stock at 7500 kb. B) Isolation product of pET-28a—LGN from 
Top10 or Supercompetent cells after transformation, all DNA detected is degraded 
below 250 bp. C) Restriction digest products pf pET-15b—LGN on 1% agarose gel. 
Lane 1) BamHI, Lane 2) NdeI, Lane 3) BamHI and NdeI, Lane 4) XhoI. 
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Figure 4: Analysis of LGN expression in E. coli cells by coomassie blue stained 
SDS-PAGE gels and Western blots. A) Western Blot after anion-exchange 
chromatography using anti-GPSM2 antibody. Lane 1) 2xYT Lysate, Lane 2) 
2xYT Flow Through and Wash, Lane 3) 2xYT Eluate, Lane 4) 2xYT Pellet Lysate, 
Lane 5) LB Flow Through and Wash, Lane 6) LB Eluate, Lane 7) LB Pellet 
Lysate. B&C) Two different cell lysates of BL21(DE3) cells after induction of 
the pET-28a—LGN. B) Coomassie blue stained protein gel after affinity 
chromatography. C) Western blot analysis using anti-His6 primary antibody 
after affinity chromatography. A faint band appeared near the bottom of the 
lane as indicated by the red circle.  
72 kDa 
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Figure 5: Analysis of sonication effects on LGN stability by coomassie blue stained SDS-PAGE gel 
and Western blot. A) Western blot analysis using anti-GPSM2 primary antibody after anion-
exchange chromatography. Lane 1) 30% amplitude lysate. Lane 2) 30% amplitude flow through. 
Lane 3) 30% amplitude eluate; Lane 4: 30% amplitude NaCl flow through #1. Lane 5) 30% 
amplitude NaCl flow through #2. Lane 6) 2.5 minute lysate. Lane 7) 2.5 minute flow-through. Lane 
8) 2.5 minute eluate. B) Coomassie blue stained protein gel after affinity chromatography. C) 
Western blot analysis using anti-GPSM2 primary antibody after affinity chromatography. B&C) 
Lane 1) Lysate of 2.5 minutes and 40% amplitude, Lane 2) Lysate of 2.5 minutes and 50% 
amplitude, Lane 3) Lysate of 3 minutes and 50% amplitude, Lane 4) Eluate of 2.5 minutes and 40% 
amplitude, Lane 5) Eluate of 2.5 minutes and 50% amplitude, Lane 6) Eluate of 3 minutes and 40% 
amplitude, Lane 7) Eluate of 3 minutes and 50% amplitude. 
in BL21(DE3) cells resulted in bands at 75 kDa as expected (Figure 4A). These results indicate that the 
pET-15b—LGN plasmid is present and viable in the E. coli cells. A stock of the E. coli with pET-15b—LGN 
in 25% glycerol was stored at -80 °C for future use. Together, these results indicate that LGN should be 
able to be readily overexpressed in the E. coli cells. This will allow for the development of a scheme to 
optimize the overexpression and purification of LGN.  
LGN Expression in E. coli and Purification 
In order to purify full length LGN protein, the 25% glycerol stock of pET-28a—LGN transformed into the 
BL21(DE3) was scraped with a pipet tip and the cells were grown in 2xYT media for LGN expression. 
After purification of the protein over a Co2+ affinity column, a SDS-PAGE gel stained with coomassie blue 
did not show a band at 75 kDa where LGN is expected to be (Figure 4B). Detection tests for LGN through 
a Western blot analysis confirmed that there was no presence of LGN (Figure 4C). It was concluded that 
either transcription or translation for LGN didn’t proceed properly or the purification scheme didn’t 
select for LGN. Thus, a different plasmid containing LGN but not a tag was pursued to ensure the tag was 
not interfering with the ability of LGN to fold correctly in the E. coli cells. 
Western blot analysis verified the presence of LGN when using the pET-15b—LGN vector (Figure 4A). In 
an attempt to increase the amount of protein being purified, multiple sonication conditions were tested. 
Sonication was performed at a reduced amplitude, 60% to 30%, or time, 5 minutes to 2.5 minutes. After 
one round of anion-exchange purification, a Western blot analysis showed that the sonication lasting 2.5 
minutes resulted in the most LGN at 75 kDa compared to the sonication at 30% amplitude which 
displayed various sized fragments of LGN (Figure 5A), indicating that LGN is being degraded. Our results 
display that a shorter time of sonication at a higher amplitude is optimal for extracting LGN from the E. 
coli cells without disrupting the integrity of 
the protein. Analysis of further 
experiments at 50% or 40% amplitude and 
3 minutes or 2.5 minutes of sonication 
time were performed. A SDS-PAGE gel 
stained with coomassie blue showed 
various bands around 75 kDa where LGN is 
expected to be (Figure 5B). Detection of 
LGN through a Western blot analysis 
confirmed the presence of LGN (Figure 5C) 
but many bands were viewed throughout 
the membrane rather than just at 75 kDa. 
The presence of more bands in lanes 5, 6, 
and 7 compared to 4 after purification 
display degradation of the protein during 
sonication procedures of greater length or 
intensity. Upon further optimization of the 
sonication protocol, our results indicated 
the presence of LGN and showed that 
vigorous sonication can disrupt the 
stability of the structure of LGN protein. It 
has been determined that sonication conditions of 2.5 minutes and 40% amplitude provide the best 
ability to lyse the E. coli cells without disrupting the stability of the LGN protein.  
Next, the binding and elution buffer pH effects on LGN purification were examined and compared to 
previous results at pH 7.3. Binding and elution buffers of pH 6.8, 7.7, and 8.0 were utilized to run the 
lysate and elute the protein from the anion-exchange column. After one round of anion-exchange 
purification at the various buffer pH values a coomassie blue stained gel showed similar protein samples 
were detected in lanes 2 through 5 at 75 kDa (Figure 6A). However, Western blot analysis showed that 
only lanes 4 and 5 displayed distinct bands near 75 kDa to identify the presence of LGN (Figure 6B). Our 
results show that both pH 7.7 and 6.8 are effective at binding LGN to the column and properly eluting it 
with the elution buffer.  
To try to increase protein expression we tested the induction of LGN overexpression using the pET-
28a—LGN and pET-15b—LGN vectors with IPTG in E. coli cells. Cell cultures that were induced with IPTG 
to express LGN were compared to 
uninduced cultures. The 
supernatant of each sample was run 
on a SDS-PAGE gel and stained with 
coomassie blue. The gel shows 
similar amounts of protein 
expressed at 75 kDa by both the 
uninduced (Lanes 1 & 3) and 
induced (Lanes 2 & 4) pET-15b—
LGN (Lanes 1 & 2) vector and pET-
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Figure 6: Analysis of buffer pH on LGN purification 
by anion-exchange chromatography by coomassie 
blue stained SDS-PAGE gel and Western blot. A) 
Coomassie blue stained protein gel after affinity 
chromatography. B) Western blot analysis using 
anti-GPSM2 primary antibody after affinity 
chromatography. A&B) Lane 1) Flow through using 
pH 8.0 buffer, Lane 2) Eluate using pH 8.0 buffer, 
Lane 3) Flow through using pH 7.7 buffer, Lane 4) 
Eluate using pH 7.7, Lane 5) Eluate using pH 6.8 
 
Figure 7: Analysis of IPTG on 
LGN expression in E. coli by 
coomassie blue stained SDS-
PAGE gel. Lane 1) pET-15b— 
LGN uninduced, Lane 2) pET-
15b—LGN induced, Lane 3) 
pET-28a—LGN uninduced, Lane 
4) pET-28a—LGN induced. 
72 kDa 
            1      2      3     4 
28a—LGN (Lanes 3 & 4) vector (Figure 7). From these results we cannot confirm the overexpression of 
LGN by either the pET-28a—LGN or pET-15b—LGN vectors and we hypothesize the protein detected by 
the anti-GPSM2 antibody was a bacterial LGN homolog. Following these results, we decided to switch to 
a mammalian system and order the pCMV—LGN vector for LGN expression.  
 
 
Immunoprecipitation & Peptide Competition for LGN Purification 
In order to successfully overexpress LGN, BHK-570 cells were transfected with pCMV—LGN and 
subsequently tested for overexpression of LGN protein. BHK-570 cells were chosen based on their 
natural expression of LGN which would suggest that overexpression of LGN would not damage the cells 
or interfere with their normal function. Immunoprecipitation was used as a method to isolate the LGN 
protein expressed in BHK-570 cells and analyzed through Western blotting. The results show that LGN 
was effectively expressed in BHK-570 cells and isolated by the immunoprecipitation, by the presence of 
a band at 75 kDa in lane 1 (Figure 8A). 
In order to purify LGN for crystallography purposes, LGN protein expressed in BHK-570 cells must be 
isolated from the cell lysate. Since the goal was to isolate LGN, the protein must be separated from the 
antibody in order to continue purification. The first method that was explored was performing an 
elution of the protein from the pellet by washing the immunoprecipitation product with a competing 
LGN peptide at varying concentrations. Samples were taken from the initial supernatant before peptide 
was added to test whether all of the LGN was binding to the beads, as well as from each supernatant 
and pellet sample after the peptide was incubated overnight with the agarose beads. Samples were run 
on SDS-PAGE gel and protein presence in each sample was analyzed by Western blot (Figure 8B). The 
band at 75 kDa revealed that the amount of anti-GPSM2 antibody used was not sufficient for binding to 
Figure 8: Western blots of LGN after immunoprecipitation using anti-
GPMS2 antibody. A) Lane 1) Transfected BHK-570 immunoprecipitation, 
Lane 2) Untransfected BHK-570 immunoprecipitation. B) 
Immunoprecipitation was followed by peptide competition. Lane 1) Initial 
supernatant before peptide wash, Lane 2) Pellet from 1:1000 peptide 
wash, Lane 3) Supernatant from 1:1000 peptide wash, Lane 4) Pellet from 
1:500 peptide wash, Lane 5) Supernatant from 1:500 peptide wash, Lane 6) 
Pellet from 1:100 peptide wash, Lane 7) Supernatant from 1:100 peptide 
wash, Lane 8) Pellet from wash without peptide, Lane 9) Supernatant from 
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all of the LGN extracted from the BHK-570 cells. Western blot analysis also did not show significant 
competition of the peptide to elute LGN into the supernatant at any concentration as shown by 
significant bands present in all pellet fractions (Lanes 2, 4, 6, and 8) and only minimal bands in all 
supernatant fractions (lanes 3, 5, 7, and 9). Peptide based elution of LGN from the anti-GPSM2 antibody 
was unsuccessful and further methods must be employed in order to isolate LGN protein from the 
immuno-precipitation product. Once a method to elute LGN from its antibody is determined, the 
purification protocol can be optimized to purify LGN to 95% so that crystallization conditions can be 
tested and subsequently protein X-ray crystallography can be performed to determine the 3D structure 
of LGN and its mutants. 
LGN Localization in BHK-570 
Analysis of LGN presence in BHK-570 was performed through cell imaging using fluorescence microscopy 
of fixed cells. Images display the presence and effective immunostaining of LGN as seen by the green 
staining in the cell which suggests effective expression of LGN in the BHK-570 cells (Figure 9A). Based on 
the normal staining of DAPI (blue), this method does not interfere with cell viability and this system can 
be used an as effective method to study the localization of patterns of LGN and its mutants throughout 
the cell cycle, during specific stages of mitosis, and its interactions with other proteins. Next, the 
localization patterns of LGN expressed through the pCMV—LGN vector in BHK-570 cells were identified 
using fluorescence microscopy (Figure 9B). In BHK-570 cells, LGN (green) was detected throughout the 
cytosol as well as concentrating to the cell cortex (bright green dots). Our analysis of the localization 
patterns of wild-type LGN protein were consistent with localization patterns of associated proteins such 
as Ric-8a (29) indicating that LGN is functioning properly in BHK-570 cells. Further microscopic 
experiments must be performed including identifying LGN localization through the phases of mitosis as 
well as LGN localization coupled with localization of associated proteins and molecules. These 
experiments will allow us to understand the functions of LGN and when coupled with 
immunofluorescence experiments with the T450 mutants of LGN, we can interpret the effects of the 
T450 phosphorylation on LGN function and activity. 
The expression levels of LGN by the pCMV—LGN vector in BHK-570 cells compared to amount of 
endogenous LGN were tested. Immunofluorescence of untransfected BHK-570 cells (Figure 9C) was 
compared to transfected cells (Figure 9D). Cells imaging revealed that minimal overexpression of LGN 
occurred in the BHK-570 cells. Although the microscopy reveals that a few cells may be overexpressing 
LGN (faint green), it cannot be concluded that overexpression is occurring due to the pCMV—LGN 
vector. Next, an alternate test of expression of LGN by the pCMV—LGN vector in BHK-570 cells was 
performed. An immunoprecipitation of untransfected BHK-570 cells was compared to transfected cells. 
Western blot analysis showed undesirable results because a significantly higher amount of LGN was 
expected in lanes 6-11, especially in lanes 8 and 10 where the LGN remained in the pellet fraction 
(Figure 9E). Based on the results from both the microscopy and immunoprecipitation, overexpression is 
not reliably occurring and the LGN detected in previous experiments was most likely endogenous LGN 
rather than the protein expressed through the pCMV—LGN vector. The initial immunoprecipitation 
results (Figure 8A) reveal that LGN expression in BHK-570 cells is possible and later attempts to transfect 
the cells could have been unsuccessful due to old reagents used in the transfection protocol. 
Furthermore, the Western blot detection is significantly more sensitive in detecting LGN than 
Figure 9: Analysis of LGN expression in BHK-570 cells by immunofluorescence and Western blot. 
A,B,C,&D) Fluorescent microscopy of LGN and nuclei in BHK-570 cells. Green fluorescence 
indicates the presence of LGN while blue fluorescence designates DNA. A) Transfected at 40x, B) 
Transfected at 100x, C) Untransfected at 40x, D) Transfected at 40x; possible overexpression is 
indicated by a faint green color and arrows, E) Western blot analysis using anti-GPSM2 primary 
antibody. Lane 1) Untransfected supernatant before wash, Lane 2) Untransfected pellet 1, Lane 3) 
Untransfected supernatant 1, Lane 4) Untransfected pellet 2, Lane 5) Untransfected supernatant 
2, Lane 6&7) Transfected supernatant before wash, Lane 8) Transfected pellet 1, Lane 9) 
Transfected supernatant 1, Lane 10) Transfected pellet 2, Lane 11) Transfected supernatant 2. 
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immunofluorescence. The efficiency of the transfection protocol needs to be optimized in order to 
consistently achieve adequate overexpression of LGN by the pCMV-LGN vector.  
  
T450 Mutagenesis 
In order to generate the LGN mutations, PCR was used to perform Stratagene’s QuikChange Site-
Directed Mutagenesis on T450 in the LGN protein sequence in the pET-28a—LGN vector. When the 
mutated T450A plasmid was run on a 1% agarose gel, no band was present at 7.5 kb (Figure 10A). The 
negative results from our initial mutagenesis suggest that the plasmid was not present in the XL1-Blue 
supercompetent E. coli initially or could possibly be degraded during the mutagenesis process. In hopes 
of replicating the minimal PCR products, the PCR product was transformed into Top10 competent cells. 
Isolation of T450A pET-28a—LGN mutant plasmid and subsequent analysis on 1% agarose gel 
electrophoresis displayed faint bands at 3700 bp (data not shown). Subsequent attempts to maximize 
pET-28a—LGN mutagenesis product only resulted in what is most likely a portion of the initial vector 
which has been degraded or cleaved in vivo over time. 
With the switch to the mammalian expression system and pCMV—LGN vector we began site-directed 
mutagenesis with the new plasmid to produce T450A and T450D LGN. PCR products were transformed 
into DH5α cells, the cells were grown in culture, a mini-prep was performed, and products were run on a 
1% agarose gel (data not shown). Only the T450D mutant products showed viable bands from the 
agarose gel electrophoresis. These products were sent to GENEWIZ for sequencing but the mutagenesis 
products that were able to be isolated from the agarose gel were not sufficiently pure to assess the 
sequence and confirm the mutation. The PCR reaction had to be refined in order to optimize product 
yield and generate a large, clean sample for sequencing. Again, site directed mutagenesis was 
performed to generate the T450A and T450D mutants. PCR products were run on a 1% agarose gel to 
analyze formation of a viable plasmid sample and to purify the sample for sequencing. Analysis of 
samples run on an agarose gel did not show significant bands at 6000 bp (Figure 10B), and the minimal 
bands present were not ample for sequencing. This further site-directed mutagenesis experimentation 
Figure 10: 1% agarose gels of PCR mutagenesis products.   A) Isolated 
T450A plasmid from E. coli colony. DNA appeared at the bottom of the lane 
near 250 bp as indicated by the red circle. B) Lane 1) T450A mutagenesis 
with Agilent polymerase enzyme. Lane 2) T450A mutagenesis with Thermo 
Scientific Phusion polymerase enzyme. Lane 3) T450D mutagenesis with 
Agilent polymerase enzyme. Lane 4) T450D mutagenesis with Thermo 
Scientific Phusion polymerase enzyme. C) First T450A nested PCR product 
at 1.4 kb. D) First T450D nested PCR product at 1.4 kb. 
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did not improve the efficiency of the PCR. Thus, we switched to a different method to generate T450A 
and T450D mutants, nested PCR. Half of the first round of nested PCR was performed to generate one 
DNA segment of the LGN sequence to use as a template for subsequent PCR experiments to generate 
the full LGN mutants. This first round of PCR used T450A (Figure 10C) and T450D (Figure 10D) mutant 
primers to generate the latter half sequences and analysis of PCR products on a 1% agarose gel shows 
the expected products at 1400 bp. These will be used in further PCR experiments to generate the full 
length LGN coding sequence which then can be ligated into an empty pCMV expression vector for 
protein expression in vivo. After successful generation of the mutant pCMV—LGN plasmid it will be sent 
to GENEWIZ for sequencing to confirm the presence of the mutation. 
Future Directions 
Next, the second half of the first round of nested PCR will be performed in order to generate the second 
segment of LGN. Both segments from the first round will be used to perform the second round of nested 
PCR and generate the full-length LGN mutants which then can be ligated into a pCMV plasmid at the 
NotI sites. These mutant LGN plasmids can then be used to express forms of LGN which mimic 
unphosphorylated and phosphorylated LGN at T450. 
Further experimentation must be performed in order to optimize BHK-570 transfection with pCMV—
LGN. In order for transfection to be optimized, we must ensure that the cells are being properly 
maintained and well-nourished with growth media, the cells must be transfected at 75-80% confluency, 
and the proper amounts of liposomal reagent and plasmid are used for the transfection. Once optimal 
transfection efficiency is confirmed, overexpressed LGN in BHK-570 cells along with molecules that 
interact either directly or indirectly with LGN will be imaged using the immunofluorescence technique 
discussed previously. Possible immunofluorescence partners for LGN include but are not limited to Gαi, 
NuMA, tubulin, dynein/dynactin, and F-Actin. Due to LGN’s function occurring during mitosis, cell cycle 
arrest will be used to synchronize cell cycles by performing serum starvation, then serum will be added 
to the cell to release them for growth. Cells will be fixed during the various stages of mitosis to allow for 
localization of LGN in BHK-570 cells during specific phases of mitosis using immunofluorescence. 
Immunofluorescence microscopy of LGN in conjunction with its direct or indirect binding partners to 
determine protein localization throughout the cell cycle will be performed. Comparing those results to 
the same experiments with T450A or T450D LGN can lead to an improved understanding of the effects 
of phosphorylation of T450 on LGN function. This understanding can lead to the development of breast 
cancer treatments which block the activation of LGN and prevent proliferation of cancer cells.  
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